Skip to main content
. 2020 Jul 18;11(7):547. doi: 10.1038/s41419-020-02753-x

Fig. 2. NCAPG correlates with poor prognosis in breast cancer.

Fig. 2

a Representative IHC images of NCAPG staining in six normal breast tissues and 103 breast specimens, which were scored as negative (0), weak (+1), moderate (+2), and strong (+3). b Distribution and comparison between NCAPG-staining grade and tumor relapse in breast cancer patients. χ2 test was used. c Kaplan–Meier analysis of overall survival and relapse-free survival curves stratified by low and high NCAPG expression in BC patients treated with trastuzumab (n = 103, log-rank test). Error bar represents the mean ± SD of three independent experiments.